SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Regulatory & Safety

Read more breaking news

 

 
News in brief

Enzon approves pharma biz sale

28-Jan-2010

Enzon stockholders have approved the sale of its pharmaceutical business, which has four marketed products and a manufacturing facility, to sigma-tau for an initial $300m (€214m).

By acquiring Enzon sigma-tau will gain a manufacturing facility in Indianapolis, Indiana, US and the marketed products Oncaspar, Adagen, DepoCyt and Abelcet.

 

The approval of Enzon’s stockholders comes after the company entered into a definitive agreement to sell the business to sigma-tau. Enzon will receive $300m from sigma-tau, plus an additional amount of up to $27m in milestone payments.

 

Furthermore, Enzon will receive royalties of five to 10 per cent on incremental net sales above a 2009 baseline.

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Products

Solid Lipid Excipients: Born to be Extruded !
Gattefossé Pharma
USP<233> Elemental Impurities Sample Prep Strategy
SGS Life Science Services
Online Cell Density Monitoring
Hamilton Bonaduz AG
Residual moisture in lyophilized pharmaceuticals
Metrohm – customized analysis for the pharmaceutical industry